Cargando…
Activation of the PERK-ATF4 pathway promotes chemo-resistance in colon cancer cells
Colon cancer is a major health problem worldwide. While chemotherapy remains a main approach for treating late-stage colon cancer patients, most, if not all, of them will develop drug resistance and die of uncontrollable disease progression eventually. Therefore, identification of mechanism of drug...
Autores principales: | Shi, Zhong, Yu, Xiaofu, Yuan, Meiqin, Lv, Wangxia, Feng, Tingting, Bai, Rui, Zhong, Haijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397152/ https://www.ncbi.nlm.nih.gov/pubmed/30824833 http://dx.doi.org/10.1038/s41598-019-39547-x |
Ejemplares similares
-
Surgical resection of the primary tumor leads to prolonged survival in metastatic pancreatic neuroendocrine carcinoma
por: Feng, Tingting, et al.
Publicado: (2019) -
Cetuximab Can Be an Effective and Low-Toxicity Maintenance Treatment Drug in Patients With Metastatic Colorectal Cancer: A Real-World Study of Zhejiang Cancer Hospital
por: Yuan, Meiqin, et al.
Publicado: (2021) -
Paclitaxel combined with capecitabine as first-line chemotherapy for advanced or recurrent gastric cancer
por: YUAN, MEIQIN, et al.
Publicado: (2014) -
miRNA-1283 Regulates the PERK/ATF4 Pathway in Vascular Injury by Targeting ATF4
por: He, Ling, et al.
Publicado: (2016) -
ER stress activates TAp73α to promote colon cancer cell apoptosis via the PERK-ATF4 pathway
por: Sun, Shengnan, et al.
Publicado: (2023)